Netskope Inc
For the period ended Oct 31, 2025. Filed Dec 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 11, 2025
NTSK$21.44-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| October 31, | January 31, | |
|---|---|---|
| 2025 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $984,652 | $166,012 |
| Marketable securities | 168,251 | 80,679 |
| Accounts receivable, net | 131,534 | 195,100 |
| Inventories | 5,377 | 5,763 |
| Deferred contract acquisition costs | 48,813 | 42,860 |
| Prepaid expenses and other current assets | 63,213 | 37,991 |
| Total current assets | 1,401,840 | 528,405 |
| Property and equipment, net | 89,544 | 99,480 |
| Operating lease right-of-use assets | 32,816 | 34,571 |
| Intangible assets, net | 23,895 | 37,242 |
| Goodwill | 61,083 | 61,083 |
| Deferred contract acquisition costs, noncurrent | 89,188 | 78,805 |
| Other assets, noncurrent | 16,670 | 18,920 |
| Total assets | $1,715,036 | $858,506 |
| Liabilities and stockholders’ equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | $16,430 | $2,652 |
| Accrued compensation and benefits | 77,471 | 62,781 |
| Deferred revenue | 471,455 | 430,156 |
| Operating lease liabilities, current | 10,124 | 10,267 |
| Accrued expenses and other current liabilities | 27,505 | 20,852 |
| Total current liabilities | 602,985 | 526,708 |
| Deferred revenue, noncurrent | 148,426 | 160,151 |
| Convertible notes | 780,365 | 626,622 |
| Operating lease liabilities, noncurrent | 24,492 | 25,808 |
| Other liabilities, noncurrent | 7,737 | 4,806 |
| Total liabilities | 1,564,005 | 1,344,095 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity (deficit): | ||
| Convertible preferred stock, $0.0001 par value: 300,000,000 shares authorized, no shares issued or outstanding as of October 31, 2025; 218,898,192 shares authorized, 218,897,608 shares issued and outstanding as of January 31, 2025 | - | 1,050,561 |
| Common stock, $0.0001 par value: No shares authorized, issued, and outstanding as of October 31, 2025; 416,163,736 shares authorized, 104,589,784 shares issued and outstanding as of January 31, 2025 | - | 10 |
| Class A common stock, $0.0001 par value; 3,000,000,000 shares authorized, 80,814,861 shares issued and outstanding as of October 31, 2025; no shares authorized, issued, and outstanding as of January 31, 2025 | 5 | - |
| Class B common stock, $0.0001 par value; 600,000,000 shares authorized and 312,226,997 shares issued and outstanding as of October 31, 2025; No shares authorized, issued, and outstanding as of January 31, 2025 | 34 | - |
| Class C common stock, $0.0001 par value; 1,000,000,000 shares authorized and no shares issued and outstanding as of October 31, 2025; No shares authorized, issued, and outstanding as of January 31, 2025 | - | - |
| Additional paid-in capital | 2,796,530 | 418,791 |
| Accumulated other comprehensive loss | (73,408) | (5,439) |
| Accumulated deficit | (2,572,130) | (1,949,512) |
| Total stockholders’ equity (deficit) | 151,031 | (485,589) |
| Total liabilities and stockholders’ equity (deficit) | $1,715,036 | $858,506 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.